← Leaderboards
Sapna Patel
University Of Tx Md Anderson Can Ctr
$711,678
Attributed
$1,045,776
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $668.2K · FY2016–22$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,045,776 · 2
By mechanism
R01$668,196 · 1
R21$377,580 · 1
Top collaborators
- Cassian Yee1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Cassian Yee$17,221,393
- John V. Heymach$11,138,593
- Anil K Sood$29,572,737
- Ferdinandos Skoulidis$4,461,361
- Michael Davies$11,575,720
Others in their field
Top investigators on “Uveal Melanoma”
- James W Harbour · Washington University$6,277,467
- Jenny J Yang · Georgia State University$4,350,201
- Anne Mary Bowcock · Washington University$4,302,378
- Jerry Niederkorn · University Of Texas Sw Med Ctr/Dallas$4,283,384
- Kendall Jay Blumer · Washington University$4,122,575
- Tina Garyantes · Linnaeus Therapeutics, Llc$4,000,000
Research focus
Uveal MelanomaClinical TrialsMalignant NeoplasmsTumorDistantImmunotherapyCutaneous MelanomaLiverMelanomaT-LymphocyteResponsePeripheral BloodCellsInfusion ProceduresAdultCancer RiskImmune Checkpoint BlockadeImmune ResistanceBlood TreatmentHepaticImmuneImmune ResponseBloodChemotherapy
Grant awards (3)
Immunotherapy of Uveal Melanoma using PRAME Vaccine in Combination with Adoptive T Cell Therapy$668,196
R01 · FY2022 · CA
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade$174,000
R21 · FY2017 · CA · contact PI
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade$203,580
R21 · FY2016 · CA · contact PI